{"id":"NCT02518191","sponsor":"Xiangyun Zong","briefTitle":"Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity","officialTitle":"Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity in Women With Breast Cancer in China","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-01","primaryCompletion":"2021-01-12","completion":"2021-01-12","firstPosted":"2015-08-07","resultsPosted":"2021-05-03","lastUpdate":"2021-06-11"},"enrollment":345,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"GnRHa","otherNames":["goserelin"]}],"arms":[{"label":"GnRHa group","type":"EXPERIMENTAL"},{"label":"None GnRHa group","type":"NO_INTERVENTION"}],"summary":"This prospective randomized controlled study is conducted to analyze the effect of Goserelin on ovarian function in women with breast cancer in China.","primaryOutcome":{"measure":"Number of Participants With Premature Ovarian Insufficiency","timeFrame":"1 years","effectByArm":[{"arm":"GnRHa (Gonadotrophin-releasing Hormone Analogues) Group","deltaMin":10,"sd":null},{"arm":"None GnRHa (Gonadotrophin-releasing Hormone Analogues) Group","deltaMin":38,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":2,"countries":["China"]},"refs":{"pmids":["16545560","12888366","16087950","17512856","23860520","9042122","16492690","19364956","15936554","17932880","10554760","17914074","15117898","23614679","20113967","17307918","21550044","24462062","25738668","35691250","34967844"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":165},"commonTop":["fatique"]}}